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Abstract
Background: The ability to establish human induced pluripotent stem cells (hiPSCs) by reprogramming of adult fibroblasts
and to coax their differentiation into cardiomyocytes opens unique opportunities for cardiovascular regenerative and
personalized medicine. In the current study, we investigated the Ca
2+-handling properties of hiPSCs derived-cardiomyocytes
(hiPSC-CMs).
Methodology/Principal Findings: RT-PCR and immunocytochemistry experiments identified the expression of key Ca
2+-
handling proteins. Detailed laser confocal Ca
2+ imaging demonstrated spontaneous whole-cell [Ca
2+]i transients. These
transients required Ca
2+ influx via L-type Ca
2+ channels, as demonstrated by their elimination in the absence of extracellular
Ca
2+ or by administration of the L-type Ca
2+ channel blocker nifedipine. The presence of a functional ryanodine receptor
(RyR)-mediated sarcoplasmic reticulum (SR) Ca
2+ store, contributing to [Ca
2+]i transients, was established by application of
caffeine (triggering a rapid increase in cytosolic Ca
2+) and ryanodine (decreasing [Ca
2+]i). Similarly, the importance of Ca
2+
reuptake into the SR via the SR Ca
2+ ATPase (SERCA) pump was demonstrated by the inhibiting effect of its blocker
(thapsigargin), which led to [Ca
2+]i transients elimination. Finally, the presence of an IP3-releasable Ca
2+ pool in hiPSC-CMs
and its contribution to whole-cell [Ca
2+]i transients was demonstrated by the inhibitory effects induced by the IP3-receptor
blocker 2-Aminoethoxydiphenyl borate (2-APB) and the phosopholipase C inhibitor U73122.
Conclusions/Significance: Our study establishes the presence of a functional, SERCA-sequestering, RyR-mediated SR Ca
2+
store in hiPSC-CMs. Furthermore, it demonstrates the dependency of whole-cell [Ca
2+]i transients in hiPSC-CMs on both
sarcolemmal Ca
2+ entry via L-type Ca
2+ channels and intracellular store Ca
2+ release.
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Introduction
The breakthrough technology introduced by Takahashi and
Yamanka in 2006 enables the derivation of pluripotent stem cells
by reprogramming of somatic cells with a set of transcription
factors [1]. Application of this reprogramming strategy to human
fibroblasts resulted in the establishment of human induced
pluripotent stem cells (hiPSCs) [2,3]. The hiPSC lines generated
were demonstrated to closely-resemble the previously described
human embryonic stem cell (hESC) lines [4], including in their
ability to differentiate into advanced cell-derivatives of all three
germ layers.
Only a limited number of studies described the ability to direct
hiPSC differentiation towards the desired cardiac-lineage
[5,6,7,8]. As a consequence very little is known about these
human iPSC-derived cardiomyocytes’ (hiPSC-CMs) functional
capabilities, and even less is known about their excitation-
contraction (E-C) coupling and Ca
2+-handling properties [5].
Thorough characterization of the functional nature of hiPSC-CMs
must be conducted before these cells can be considered as
candidates for the emerging fields of regenerative medicine
(potentially providing autologous cardiomyocytes for myocardial
regeneration strategies) and personalized medicine (for the
derivation of patient/disease-specific in-vitro models of human
cardiac tissue). The suitability of hiPSC-CMs for such tasks
depends, in part, on their contractile characteristics which in turn
greatly depend on the Ca
2+-handling nature of these cells.
In adult ventricular cardiomyocytes, Ca
2+-handling displays a
well-defined sequence of events. Ca
2+ influx into the cells via
depolarization-activated L-type Ca
2+ channels serves as an initial
trigger that is then amplified several folds by sarcoplasmic
reticulum (SR) Ca
2+-store release via Ca
2+-sensitive ryanodine
receptors (RyRs); a process known as Ca
2+ induced Ca
2+ release
(CICR) [9,10]. Nevertheless, exceptions to the CICR model have
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cytes with whole-cell [Ca
2+]i transients being derived solely from
Ca
2+ influx through the membrane Ca
2+ channels [11,12,13] or
by spontaneous release from the intracellular Ca
2+ stores [14].
In the current study, we tested the hypothesis that whole-cell
[Ca
2+]i transients in hiPSC-CMs are dependent on both transsarco-
lemmal Ca
2+ entry via L-type Ca
2+ channels and on intracellular
store Ca
2+ release. To test this hypothesis, we initially carried out
gene expression and immunostaining studies to show that key Ca
2+-
handling proteins are expressed in hiPSC-CMs. To test for their
functionality we then performed detailed laser-confocal Ca
2+
imaging coupled with targeted pharmacological interventions.Initial
studies confirmed the importance of transsarcolemmal Ca
2+ entry
through the L-type Ca
2+ channels for modulation of the whole-cell
[Ca
2+]i transients in these cells. We then demonstrated that hiPSC-
CMs display functional and loaded RyR-regulated intracellular
Ca
2+ stores that contribute aswellto the whole-cell[Ca
2+]i transient.
In addition, we investigated the functionality of SR Ca
2+ ATPase
(SERCA) pumps, which serve as an important SR Ca
2+ sequestra-
tion pathway. We found the SERCA pumps to be functional and
responsible for the refilling of hiPSC-CMs’ SR Ca
2+ store content.
Finally, we also present evidence showing the expression and
functionality of inositol-1,4,5-trisphosphate receptors (IP3Rs) in
hiPSC-CMs and demonstrate the important contribution of this
alternative pathway to Ca
2+-handling in these cells.
Methods
Differentiation of hiPSCs into cardiomyocytes
The hiPSC line utilized in the current study (hIH-1) was
recently established in our laboratory [15] by retroviral delivery of
three reprogramming factors: OCT4, SOX2, and KLF4 together
with valproic acid (VPA), a histone deacetylase inhibitor
potentiating the reprogramming ability of these factors [16]. This
hiPSCs line was demonstrated to fulfill all the criteria defining the
iPSC state including full reprogramming, pluripotency, and
genetic stability [15]. In the current study we used two clones
(hIH-1 clones 1&2) of this line that were derived independently
during reprogramming of the human fibroblasts. In addition, we
also studied a second well-characterized hiPSCs line (hFib2-iPS
cells; kindly provided by G.Q Daley) [8,17], which was established
by retroviral transduction of human fibroblasts with OCT4, SOX2,
c-MYC, KLF4, together with hTERT and SV40-large T [17].
Undifferentiated hiPSC colonies were cultured on a mitotically-
inactivated MEF feeder layer [8]. The culture medium consisted
of 80%-knockout high-glucose glutamine-free DMEM with
sodium-pyruvate supplemented with 20%-serum-replacement,
1 mM L-glutamine, 0.1 mM mercaptoethanol, 4 ng/mL human
recombinant basic fibroblast-growth-factor, and 1%-nonessential
amino acid stock (Invitrogen).
To induce differentiation, hiPSCs were dispersed into small
clumps using collagenase-IV (Life-Technologies, 1 mg/mL,
20 min) and cultivated in suspension where they aggregated to
form embryoid bodies (EBs). The EBs were plated after 10 days on
gelatin-coated culture dishes and observed for the appearance of
spontaneous contracting areas. The beating areas within the EBs
were mechanically microdissected at 30–50 days following the
appearance of spontaneous beating to allow comparison with
studies assessing hESC-derived cardiomyocytes at similar devel-
opmental stages [18,19]. This was followed by enzymatic
dispersion (1 mg/ml collagenase B, Roche, Mannheim, Germany)
at 37uC for 30 min to derive single cardiomyocytes or small
monolayered clusters. After dispersal, the cells were plated onto
fibronectin-coated glass coverslips for experimentation.
Reverse transcription PCR (RT-PCR) analysis
The expression of various cardiac Ca
2+-handling genes was
tested using semi-quantitative RT-PCR. Total RNA was extracted
from human embryonic kidney cells (HEK293, American Type
Culture Collection (ATCC), Manassas, VA) and from beating
hiPSC-CMs using RNeasy Mini Kit (Qiagen). cDNA was
synthesized using Verso
TM-RT-PCR-Kit (Thermo-Scientific).
1.6 ng of cDNA was subjected to the following PCR program:
3 min at 93uC, 30 sec at 93uC, 30 sec at 60uC, and 30 sec at
72uC. The PCR-related primers are detailed in Table 1.
Immunocytochemistry
Single cells and small monolayered clusters were fixed using 4%
paraformaldehyde and permeabilized with 1% Triton-X-100
(Sigma). Cells were blocked with 5% horse serum and 1% bovine
serum albumin and incubated overnight at 4uC with primary
antibodies targeting sarcomeric a-actinin (1:200, Sigma-Aldrich),
ryanodine receptor (1:1,000, Chemicon), and pan-IP3R (reacting
with the C-terminal cytoplasmic domain of IP3R types 1, 2, and 3)
(1:10, Millipore). The secondary antibodies were Cy3-conjugated
donkey anti-mouse and Cy2-conjugated goat anti-rabbit IgG
antibodies at 1:200 for 1 h (Jackson). Nuclei were counterstained
with DAPI (Sigma). Preparations were examined using a laser-
scanning confocal microscope (Zeiss LSM-510-PASCAL).
Ca
2+ Imaging
Cells were loaded with 5 mM fluo-4 fluorescent Ca
2+ indicator
(Molecular Probes) in the presence of Pluronic F-127 (Molecular
Probes) at a dilution of 2:1 to allow the recording of intracellular
Ca
2+-transients (whole-cell [Ca
2+]i transients) as previously
described [18]. Experiments were conducted in the presence of
indicator-free tyrode solution containing in mM: NaCl-140, KCl-
5.4, CaCl2-1.8, MgCl2-1, HEPES-10, glucose-10 at pH 7.4 via
1 mM NaOH. The tyrode solution was superfused at a rate of
1 ml/minute and at a temperature of 37uC. Intracellular Ca
2+-
transients were recorded using a confocal imaging system (Fluo-
view; Olympus) mounted on an upright BX51WI Olympus
Table 1. Primers names and sequences.
Gene Primer
CaV1.2 S TGACATCGAGGGAGAAAACT
CaV1.2 A.S ACATTAGACTTGACTGCGGC
RyR2 S TAGATTTATAAGGGGCCTTG
RyR2 A.S GATTCTTCAGGGCTCGTAGT
IP3R2 S GAAGAAACTACAGCACGCTG
IP3R2 A.S TTCTCCAGTAAAGCAGGTAA
SERCA2 S GAGAACGCGCACACCAAGA
SERCA2 A.S TTGGAGCCCCATCTCTCCTT
Calsequestrin S ATAGAGTTTGATGGCGAGTT
Calsequestrin A.S TGATGTAGTCTTCAATGCGT
Phospholamban S CTGCCAAGGCTACCTAAAAG
Phospholamban A.S AGCTGAGCGAGTGAGGTATT
b-Tubulin S CCGGACAGTGTGGCAACCAGATCG
b-Tubulin A.S TGGCCAAAAGGACCTGAGCGAACGG
Abbreviations: CaV1.2, L-type Ca
2+ channels; RyR2, ryanodine receptor; IP3R2,
inositol 1,4,5-triphosphate receptor; SERCA2, SR Ca ATPase;.
doi:10.1371/journal.pone.0018037.t001
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analyzed utilizing MatLab-based custom-written software.
To investigate caffeine mobilization of store Ca
2+, temporally-
limited puffs of caffeine were applied. This specific technique [18]
was chosen to overcome the technical issue of the rate of caffeine
delivery to the cells. The caffeine puff (20 mM, ,2s) was applied
by pressure-ejection through a pipette situated approximately
100 mm away from the target cells’ position. The focal puff pipette
was positioned central to the plane of the line scan and in the
direction of constant bulk flow of the tyrode solution.
Statistical analysis
Data are presented as mean 6 standard error of mean (SEM).
Student’s paired t-test was used to compare between means. When
the effects of multiple concentrations of the pharmacological
agents were studied, then one way ANOVA was used followed by
Dunnet’s post-hoc comparison to baseline values. p,0.05 was
considered to be statistically significant.
Results
Expression of Ca
2+-handling molecules in hiPSC-CMs
To evaluate whether cardiac-related Ca
2+-handling molecular
components are present in the hiPSC-CMs, we first used semi-
quantitative RT-PCR analysis. We assessed for the expression of
the following Ca
2+-handling proteins: RyR2, IP3R2, SERCA2a,
Cav1.2 (encoding the a-1C subunit of the L-type Ca
2+ channel),
Calsequestrin, and Phospholamban. As can be seen in Figure 1, all
of these genes were expressed in the hiPSC-CMs while absent in
control HEK293 cells.
Spontaneous whole-cell [Ca
2+]i transients in hiPSC-CMs
Spontaneous whole-cell [Ca
2+]i transients in hiPSC-CMs were
recorded from spontaneously beating dispersed single cells or small
monolayered clusters, under native cytosolic conditions. These
transients were monitored in Fluo-4 (a fluorescent Ca
2+ indicator)
loaded cells, examined under a laser scanning confocal microscope
utilizing the line-scan mode. Line scans were adjusted to avoid the
cell nuclei and were localized at mid-cell z-section depth. Under
control conditions, in the presence of 1.8 mM external bath Ca
2+,
spontaneous whole-cell [Ca
2+]i transients were recorded as cell-
wide rhythmic events in all cells tested (n=96) (Figure 2A).
Ca
2+ influx via L-type Ca
2+ channels contributes to
whole-cell [Ca
2+]i transients
Transmembranal Ca
2+ influx is an important initial trigger for
excitation-contraction coupling in adult cardiomyocytes [9] and in
hESC-derived cardiomyocytes (hESC-CMs) [19]. Therefore, the
next step was to investigate whether the development of hiPSC-
CMs whole-cell [Ca
2+]i transients require external Ca
2+. To this
end, we recorded whole-cell [Ca
2+]i transients in the presence
(1.8 mM bath Ca
2+) and absence of Ca
2+ in the bath solution
(n=6). As can be appreciated in Figure 2B, in the absence of bath
Ca
2+ the whole-cell [Ca
2+]i transients were completely abolished.
To test whether the L-type Ca
2+ channel serves as an important
transmembranal Ca
2+ influx pathway in hiPSC-CMs, as docu-
mented in adult cardiomyocytes [9], we tested the effect of
Nifedipine, a L-type Ca
2+ channel blocker. Whole-cell [Ca
2+]i
transients were recorded before and after the application of 1 mM
Nifedipine (Figure 2C). Similarly to what was observed in the
absence of bath Ca
2+ (Figure 2B), 1 mM Nifedipine led to the
complete elimination of whole-cell [Ca
2+]i transients (n=9). Dose-
response studies using lower concentrations of nifedipine (0.05–
1 mM, n=6) demonstrated that the cells were extremely sensitive to
L-type channel blockade with a steep decrease in [Ca
2+]i transients
amplitude observed at a very low concentration (Figure 2D).
To verify that the results obtained were not due to clonal or line
variations, we compared the results obtained in cardiomyocytes
differentiated from two different clones of the main hiPSC line
studied (hIH1 - clones 1&2 derived independently from the human
fibroblasts) as well as from an additional well-characterized hiPSC
line (hfib2-5) derived using the traditional 4-factors method [8,17].
The dependency of whole-cell [Ca
2+]i transients on the presence of
functional L-type Ca
2+ channels was found to be independent of
the specific hiPSC clone or line used. Thus, Nifedipine (1 mM)
application resulted in complete elimination of whole-cell [Ca
2+]i
transients in all cases (Figure S1).
Taken together these data confirm that transmembranal Ca
2+
influx and specifically Ca
2+ entry via L-type Ca
2+ channels are
important requirements for the generation of whole-cell [Ca
2+]i
transients in hiPSC-CMs.
Functional RyR-mediated intracellular Ca
2+ stores exist
and contribute to whole-cell [Ca
2+]i transients
We next conducted immunocytostaining studies of hiPSC-CMs
probing for both RyR2 and sarcomeric a-actinin in small monolay-
ered clusters (Figure 3A). As previously shown in hESC-CMs [18,21]
sarcomeric a-actinin staining in hiPSC-CMs displayed a relatively
disorganized striated sarcomeric arrangement (Figure 3A, left). RyR2
expression was exhibited throughout the cytosol (Figures 3A, middle),
with some myofilaments co-localization (Figure 3A, right). The
perinuclear region displayed intense staining as was similarly observed
in mouse ESC-CMs [22] and hESC-CMs [18].
To determine whether hiPSC-CMs possess loaded SR Ca
2+
stores that release Ca
2+ via functional RyRs we tested for caffeine
responsiveness. Caffeine mobilization of store Ca
2+ and its effect
on whole-cell [Ca
2+]i transients were measured by applying a
pressure-ejected caffeine puff (20 mM, 2 sec) on to fluo-4 loaded
hiPSC-CMs. As can be observed in Figure 3B, caffeine application
elicited an instantaneous, rapid, and large release of Ca
2+ from the
intracellular stores, resulting in a high amplitude caffeine-induced
Ca
2+ transient (n=26). This was followed by reversible quiescence
of whole-cell [Ca
2+]i transients (Fig. 3B) postulated to be a
consequence of intracellular Ca
2+ stores depletion. This phenom-
enon was noted in cardiomyocytes derived from all hiPSCs clones
and lines studied (Figure S2A). Finally, dose-response studies (10,
Figure 1. Semi-quantitative RT-PCR analysis for cardiac-
specific Ca
2+-handling proteins in hiPSC-CMs. Gene expression
pattern of proteins involved in Ca
2+-handling in hiPSC-CMs (upper
panel) and control HEK293 cells. The lower panel displays genes
expression in control HEK293 cells. b-tubulin was used as a normalizing
house-keeping gene. Abbreviations: RyR2, ryanodine receptor; IP3R2,
inositol 1,4,5-triphosphate receptor; SERCA2a, SR Ca ATPase; CaV1.2, L-
type Ca
2+ channels; Cal, calsequestrin, and PLN, phospholamban.
doi:10.1371/journal.pone.0018037.g001
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with an increase in the relative magnitude of caffeine-induced
Ca
2+ release (Figure 3C).
Next, it was important to validate that the caffeine-induced
[Ca
2+]i transient was indeed a consequence of RyR-mediated SR
Ca
2+ release. To exclude the plausible contribution of Ca
2+ influx
through voltage-gated Ca
2+ channels 20 mM caffeine puffs were
applied in the presence (1.8 mM Ca
2+; Figure 3D, left) and absence
(Figure 3D, right) of bath Ca
2+. Similarly to what was observed
under control conditions (Figure 3D, left), caffeine puffs applied in
the absence of bath Ca
2+ (n=6) induced an instantaneous rapid
caffeine-induced [Ca
2+]i transient (Figure 3D, right) displaying an
amplitude similar to that observed under control conditions. To
exclude the possibility that the caffeine-induced [Ca
2+]i transient
Figure 2. Whole-cell [Ca
2+]i transients in hiPSC-CMs and their requirement for Ca
2+ influx via L-type Ca
2+ channels. (A) Confocal line-
scan images showing changes in intracellular Ca
2+ in a fluo-4 loaded hiPSC-CM (derived from the hIH1 line). The images showing spontaneous whole-
cell [Ca
2+]i transients are displayed either as a distance-time plot (upper panel) or as a line-scan tracing (lower panel). (B) Whole-cell [Ca
2+]i transients
in the presence (left) and absence (right) of bath Ca
2+.( C) Whole-cell [Ca
2+]i transients before (left) and after (right) application of nifedipine (1 mM).
(D) Dose-response curve showing the percentage of decrease in [Ca
2+]i transients amplitude relative to baseline conditions as function of nifedipine
concentration (0.05, 0.1 and 1 mM, n=6). *p,0.05 and **p,0.01 when mean absolute values were compared to baseline values. Abbreviations: F/Fo,
fluorescence (F) normalized to baseline fluorescence (Fo); sec, seconds.
doi:10.1371/journal.pone.0018037.g002
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by the actual pressure injected puff, control puff (tyrode solution)
trials were conducted. These control puffs did not trigger any
apparent intracellular Ca
2+ response (data not shown).
Finally, we also tested the effect of ryanodine, a RyR antagonist.
For this purpose we monitored whole-cell [Ca
2+]i transients before
(Figure 4A, left) and after (Figure 4A, right) applicationof ryanodine
(10 mM). Ryanodine administration led to a significant reduction in
Ca
2+ release, as observed by the decrease in whole-cell [Ca
2+]i
transients amplitude (Figure 4B; n=14; p,0.05) and also to
significant slowing of whole-cell [Ca
2+]i transients frequency
(Figure 4C; n=6; p,0.05). The effect of ryanodine was noted in
cardiomyocytes derived from all hiPSC clones and lines studied
(Figure S2B) and was dose-dependent, as increasing doses of
ryanodine (5, 10, 15, and 20 mM, n=8) led to a gradual decrease in
whole-cell [Ca
2+]i transients amplitude in both lines studied
(Figures 4D and S2C). Taken together, these data demonstrate
that hiPSC-CMs display caffeine-responsive and ryanodine-sensi-
tive SR Ca
2+ stores capable of unloading Ca
2+ via RyR-mediated
Ca
2+ release and contributing to whole-cell [Ca
2+]i transients.
SERCA-mediated SR Ca
2+ uptake is required for
whole-cell [Ca
2+]i transients
We next tested for the functionality and contribution of another
important Ca
2+-handling protein situated on the SR membrane,
SERCA. To test for SERCA functionality in hiPSC-CMs we
Figure 3. Localization and functionality of Ca
2+ store ryanodine receptors. (A) A hIH1 hiPSC-CM co-labeled with antibodies for sarcomeric
a-actinin (left) and RyR2 (middle). The merged image is displayed in the right panel. (B) A line-scan presenting the effect of 20 mM caffeine puff
application (noted by the arrows). (C) A dose-response curve displaying the magnitude of the caffeine-induced Ca
2+ release (quantified by the
percentage increase of the amplitude of the caffeine-induced transient relative to the preceding action-potential induced [Ca
2+]i transient) as
function of the caffeine bolus dosage (10, 20 and 40 mM). *p,0.05 when compared to the lowest (10 mM) dosage. (D) A line-scan tracings
presenting caffeine-induced Ca
2+ transients in the presence (left) and absence (right) of bath Ca
2+. Abbreviations: F/Fo, fluorescence (F) normalized to
baseline fluorescence (Fo); sec, seconds.
doi:10.1371/journal.pone.0018037.g003
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2+]i transients before (Figure 5A, left) and
after (Figure 5A, right panel) application of 10 mM thapsigargin, a
specific SERCA inhibitor. Application of 10 mM thapsigargin
(15 min incubation) resulted in a decrease in whole-cell [Ca
2+]i
transients’ amplitude in both lines studied (n=7, Figure 5A, and
Figure S3A). The effect of thapsigargin was dose-related with a
greater decrease in whole-cell [Ca
2+]i transients amplitude
(observed at 15 min following drug application) with escalating
doses (1, 5, 10 and 20 mM, Figure 5B).
We have shown above (Figures 3, 4, 5A) that in the case of
hiPSC-CMs SR Ca
2+ release is an important contributor of whole-
cell [Ca
2+]i transients. Therefore, we wanted to confirm whether
the inhibiting effect of thapsigargin on whole-cell [Ca
2+]i transients
was due to a decrease in SR Ca
2+ content, as a consequence of
SERCA Ca
2+ uptake inhibition. To this end we conducted
repeated SR Ca
2+ load measurements by applying 20 mM
caffeine puffs under control conditions (Figure 5C, upper panel)
and in the presence of 10 mM thapsigargin (Figure 5C, middle and
lower panels). In contrast, to the enhanced caffeine-induced
[Ca
2+]i transient observed under control condition (Figure 5C,
upper panel), application of a caffeine puff, when complete
succession of all whole-cell [Ca
2+]i transients has taken place as a
Figure 4. Ryanodine-sensitive Ca
2+ stores. (A) Line-scan tracings of whole-cell [Ca
2+]i transients recorded from a representative hIH1 hiPSC-CM
under control conditions (left) and in the presence of 10 mM Ryanodine (right). (B–C) Summary of the ryanodine-mediated (10 mM) diminution in
whole-cell [Ca
2+]i transients amplitude (B) and frequency (C). *p,0.05 when compared to baseline (control) values. (D) Dose-response curve for the
effects of ryanodine (5, 10, 15 and 20 mM) on whole-cell [Ca
2+]i transients amplitude displayed as the percentage of decrease from baseline values.
**p,0.01 when mean absolute values were compared to baseline values. Abbreviations: F/Fo, fluorescence (F) normalized to baseline fluorescence
(Fo); sec, seconds.
doi:10.1371/journal.pone.0018037.g004
Calcium Handling in hiPSC-CMs
PLoS ONE | www.plosone.org 6 April 2011 | Volume 6 | Issue 4 | e18037result of the thapsigargin uptake inhibition, produced only a minor
effect. This effect was displayed as a miniscule caffeine-induced
[Ca
2+]i transient (Figure 5C, middle panel), that was completely
omitted in the subsequent caffeine puff (n=7; Figure 5C, lower
panel). A similar phenomenon was also observed in cardiomyo-
cytes derived from a second hiPSC line (hfib2-5, Figure S3B). The
absent caffeine-induced signal at this stage is postulated to be a
consequence of the inability of the SR to reload due to SERCA
uptake inhibition by thapsigargin.
IP3-mediated calcium release contributes to whole-cell
[Ca
2+]i transients
IP3-dependent signaling has been shown to play an important
role during the process of cardiac development [23,24]. It was
recently demonstrated that in both mouse [25,26] and human
[18,27] ESC-CMs an IP3-releasable Ca
2+ pool is expressed and
functional. To evaluate the potential role of an IP3-releasable Ca
2+
pool in hiPSC-CMs, we first utilized immunocytostaining to detect
the presence of the IP3R. These stainings displayed positive IP3R
immunosignal, strongly distributed around the nucleus (Figure 6A),
in a similar fashion to that observed in neonatal rat cardiomyo-
cytes [28], mouse ESC-CMs [26], and hESC-CMs [18].
To assess the potential contribution of the IP3R to the
modulation of whole-cell [Ca
2+]i transients in hiPSC-CMs, we
tested the effect of IP3R blockade utilizing two different
antagonistic approaches. First, whole-cell [Ca
2+]i transients were
recorded before (Figure 6B, left) and after (Figure 6B, right)
application of a low concentration of 2-aminoethoxyphenyl borate
(2-APB, 2 mM, n=14), a well-known cell-permeate IP3R
antagonist. 2-APB application resulted in a significant decrease
in whole-cell [Ca
2+]i transients amplitude (Figures 6B,D) and
significantly slowed down whole-cell [Ca
2+]i transients frequency
Figure 5. The effects of SERCA inhibition. (A) Line-scan tracings of whole-cell [Ca
2+]i transients in a hIH1 hiPSC-CM under control conditions
(left) and after 15 minutes (right) of continuous 10 mM thapsigargin exposure. (B) Dose-response effects of thapsigargin (1, 5, 10 and 20 mM) on
[Ca
2+]i transients amplitude (displayed as percentage decrease versus baseline values). *p,0.05 and **p,0.01 when mean absolute values were
compared to baseline values. (C) Caffeine-induced Ca
2+ transients (denoted by arrows) under control conditions (upper), after 30 minutes (middle),
and 32 minutes (lower) of thapsigargin exposure. Abbreviations: F/Fo, fluorescence (F) normalized to baseline fluorescence (Fo); sec, seconds.
doi:10.1371/journal.pone.0018037.g005
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and 10 mM; n=8) as displayed in Figure 6E. Strengthening the
above-mentioned results, application of 2 mM of U73122 (a
phosopholipase C inhibitor, n=15) led to a significant diminution
of whole-cell [Ca
2+]i transients amplitude (Figure 6C–D) and a
slowing of whole-cell [Ca
2+]i transients frequency (Figure 6C–D).
This effect was dose-dependent (0.5, 1, 2, and 3 mM; n=8;
Figure 6E). The effects of 2-APB and U73122 were found to be
independent of the hiPSC line used (Figure 6 and Figure S4).
These observations imply that in hiPSC-CMs an IP3-releasable
Ca
2+ pool is functional and contributes to the modulation of Ca
2+-
handling in these cells.
Discussion
The ability to derive hiPSCs by reprogramming of adult human
fibroblasts [2,3] coupled with the capability to coax the
differentiation of the generated hiPSCs into the cardiac lineage
[6,7,8] opens unique opportunities for basic and translational
cardiovascular research. Yet, to fulfill the promise of this unique
Figure 6. IP3Rs localization and function. (A) A hIH1 hiPSC-CM co-stained for pan-IP3R (middle) and sarcomeric a-actinin (left). Merged images
are presented in the right panel. (B) Whole-cell [Ca
2+]i transients before (left) and after (right) 2-APB (2 mM) application. (C) Whole-cell [Ca
2+]i
transients before (left) and after (right) U73122 (2 mM) application. (D) Summary of the effects of 2-APB and U73122 on whole-cell [Ca
2+]i transients
amplitude and frequency. *p,0.05 when compared to baseline values. (E–F) Dose-response curves displaying the effects of 2-APB (0.1, 0.5, 1, 2, 5 and
10 mM) (E) and U73122 (0.5, 1, 2 and 3 mM) (F) on whole-cell [Ca
2+]i transients amplitude (displayed as the relative decrease (%) versus baseline
values). *p,0.05 and **p,0.01 when mean absolute values were compared to baseline values. Abbreviations: F/Fo, fluorescence (F) normalized to
baseline fluorescence (Fo); IP3R, inositol-1,4,5-trisphosphate receptor; sec, seconds.
doi:10.1371/journal.pone.0018037.g006
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personalized medicine, it is important that the generated hiPSC-
CMs express a cardiomyocyte-specific phenotype; possessing,
among other requirements, functional excitation-contraction
coupling components.
In the current study, we focused on studying the Ca
2+-handling
properties of hiPSC-CMs. Our major findings consist of the
following: (1) Mature molecular components RyR2, IP3R2,
SERCA2a, CaV1.2, calsequestrin, and phospholamban are
expressed in these cells; (2) hiPSC-CMs display spontaneous
whole-cell [Ca
2+]i transients; (3) Ca
2+ entry via L-type Ca
2+
channels is required for triggering whole-cell [Ca
2+]i transients;
(4) Caffeine-responsive and ryanodine-sensitive Ca
2+ stores are
loaded and functional; (5) RyR-mediated SR Ca
2+ release
contributes to whole-cell [Ca
2+]i transients; (6) SERCA pumps
are functional and enable the refilling of SR Ca
2+ content,
required for the modulation of whole-cell [Ca
2+]i transients; (7)
An IP3-releasable Ca
2+ pool is expressed, functional, and
contributes to whole-cell [Ca
2+]i transients; and (8) the results
obtained are comparable in cardiomyocytes derived from
different differentiation experiments of the same hiPSC line,
from different hiPSC clones (derived independently from
fibroblasts of the same individual), and from different hiPSCs
lines established using different techniques (using either three or
four reprogramming factors). Taken together we conclude that
whole-cell [Ca
2+]i transients in hiPSC-CMs depend on both Ca
2+
influx via L-type Ca
2+ channels and intracellular Ca
2+ store
release, as previously documented in mouse [25,26] and human
ESC-CMs [18,19].
Whole-cell [Ca
2+]i transients in hiPSC-CMs depend on
Ca
2+ entry via L-type Ca
2+ channels and Ca
2+ release from
RyR-mediated SR Ca
2+ stores
In adult cardiomyocytes the development of an action potential
triggers the opening of L-type Ca
2+ channels. The resulting Ca
2+
influx serves as a trigger for activating RyR-mediated SR Ca
2+
release by a mechanism known as CICR [9,10]. In addition to the
well-established CICR mechanism in adult mammalian cardio-
myocytes other mechanistic models were also proposed to be
responsible for E-C coupling in various species and at earlier
cardiomyocyte developmental stages. These include reports in frog
[13] and turtle [11] adult ventricular cells as well as in primary
embryonic murine myocytes [12], in which whole-cell [Ca
2+]i
transients were shown to be derived solely from Ca
2+ influx
through membrane Ca
2+ channels. In contrast, global whole-cell
[Ca
2+]i transients in early cardiac cells derived from mouse ESC
[14] were reported to be the result of spontaneous Ca
2+ release
from intracellular Ca
2+ stores without the triggering of membrane
Ca
2+ currents.
The mechanism underlying E-C coupling in hESC-CMs is
somewhat controversial. While some reports suggested the
absence of a functional SR Ca
2+ store in hESC-CMs and
postulated that essentially all of the [Ca
2+]i transients in these
cells were a consequence of transsarcolemmal Ca
2+ influx via
membranal Ca
2+ channels [29], others have argued for a more
mature-like CICR mechanism [18,19,30]. The latter studies
reported the presence of a functional caffeine-responsive and
ryanodine-sensitive SR Ca
2+ s t o r ei na tl e a s tas u b s e t[ 3 0 ]i fn o t
all [18,19], of the cells tested; in a similar manner to the hiPSC-
CMs studied in the current study.
Our results support the contribution of both the transsarco-
lemmal Ca
2+ influx and intracellular Ca
2+ store release to whole-
cell [Ca
2+]i transients in hiPSC-CMs. The importance of the L-
type Ca
2+ current in generating whole-cell [Ca
2+]i transients in
these cells was manifested by the elimination of these transients in
the absence of external Ca
2+ or in the presence of nifedipine, a
selective L-type Ca
2+ channel antagonist. A similar requirement
for external Ca
2+ and the consequent transsarcolemmal Ca
2+
influx was documented in adult cardiomyocytes [9,31,32], hESC-
CMs [19] and mouse ESC-CMs [33,34].
The contribution of Ca
2+ release from intracellular SR Ca
2+
stores to whole-cell [Ca
2+]i transients was demonstrated by
pharmacological studies interfering either with SR Ca
2+ release
(caffeine and ryanodine) or reuptake (thapsigargin). Caffeine
increases RyR2s opening, leading to a single large-amplitude
caffeine-induced Ca
2+ transient, considered to be a descriptive
index of the level of SR Ca
2+ load [35]. In hiPSC-CMs a local
pressure ejected puff of caffeine elicited a local bolus release of
Ca
2+, followed by a short and reversible succession of whole-cell
[Ca
2+]i transients. These results suggest that caffeine induced
depletion of the SR Ca
2+ store and point to a whole-cell [Ca
2+]i
transient dependency on SR Ca
2+ content.
The main Ca
2+ source for the caffeine induced [Ca
2+]i increase
is RyR-mediated SR Ca
2+ release and is not dominated by Ca
2+
influx via voltage-gated Ca
2+ channels. This was demonstrated by
the similar caffeine-induced rise in intracellular Ca
2+ documented
in the absence of extracellular bath Ca
2+ further confirming the
presence of a caffeine-responsive intracellular Ca
2+ store. Similar
results were also acquired in hESC-CMs [18,19].
We also applied the RyR antagonist, ryanodine, to further study
hiPSC-CMs RyR-mediated SR Ca
2+ release. Ryanodine, has been
reported to reduce by approximately twofold the conductance of
RyRs in the SR [36]. In hiPSC-CMs, ryanodine application led to
a dose-dependent diminution in Ca
2+ release observed as a
significant decrease in the amplitude of whole-cell [Ca
2+]i
transients. A similar ryanodine induced effect was also reported
in pacemaker cells isolated from rabbit sinoatrial node [37], in
ESC-CMs [18,30] and in mouse ESC-CMs [33]. In addition, in
hiPSC-CMs ryanodine application also resulted in slowing of the
spontaneous whole-cell [Ca
2+]i transients firing rate. This
phenomenon was also previously documented in rabbit sinoatrial
node pacemaker cells where a similar slowing in firing rate was
detected in the presence of ryanodine [37].
Functional SERCA pumps enable the loading of SR Ca
2+
store content required for whole-cell [Ca
2+]i transients
For cellular relaxation to take place Ca
2+ must be removed from
the cytosol. In adult cardiomyocytes, one of the main Ca
2+
removal pathways is the SR Ca
2+ ATPase pump (SERCA) [9,38].
These pumps decrease intracellular Ca
2+, by sequestering Ca
2+
back into the SR, and in this manner also regulate SR Ca
2+ load
[38]. In adult human cardiomyocytes, SERCA pumping activity is
responsible for 70% of Ca
2+ sequestration from the cytosol back
into the SR [9]. To investigate the functionality and contribution
of the SERCA pumps to whole-cell [Ca
2+]i transients through
their ability to reload the SR Ca
2+ stores in hiPSC-CMs we
applied the SERCA inhibitor thapsigargin. Thapsigargin acted
slowly to progressively decrease the amplitude of whole-cell
[Ca
2+]i transients, eventually leading to their complete inhibition.
A similar effect was observed in spontaneously beating fluo-4
loaded isolated mouse ESC-CMs
34. An antagonistic effect of
thapsigargin on [Ca
2+]i transients was also reported in human
ESC-CMs [19,30].
The key role of SERCA in reloading the SR, and thereby
indirectly modulating hiPSC-CMs whole-cell [Ca
2+]i transients,
was further demonstrated by the miniscule effect of caffeine in
hiPSC-CMs pretreated with thapsigargin, as a result of a
pronounced diminution in SR Ca
2+ content. Interestingly,
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low SR Ca
2+ content was retained yet [Ca
2+]i transients were
completely abolished. This can be explained by reports showing
that decrease in SR Ca
2+ content can disproportionately inhibit
SR Ca
2+ release [39], which as shown here is an important
contributor to hiPSC-CMs whole-cell [Ca
2+]i transients. In an
immediate subsequent caffeine puff the caffeine-induced
[Ca
2+]i transient was completely omitted. The absent caf-
feine-induced signal at this stage is postulated to be a
consequence of caffeine induced depletion of the SR Ca
2+
store and the inability of the SR to accumulate Ca
2+ as a result
of the thapsigargin treatment.
IP3R expression, function, and contribution to whole-cell
[Ca
2+]i transients in hiPSC-CMs
IP3-mediated Ca
2+ release presents a fundamental pathway for
intracellular Ca
2+ release in electrically non-excitable adult cells
[40]. While, in adult cardiomyocytes IP3Rs contribution to
cardiac physiology has remained elusive and controversial
[9,41,42] they have been shown to play an important role during
the process of cardiac development [23,24,42]. In fact, in the
embryo the IP3R is reported to be the first expressed Ca
2+ release
channel [24,42].
The IP3Rs have been reported to contribute to spontaneous
activity in mouse ESC-CMs [25,26] and are expressed and
functional in hESC-CMs [18,27]. To test for functionality and a
potential contribution of an IP3-releasable Ca
2+ pool to the
modulation of Ca
2+-handling in hiPSC-CMs we first examined the
expression and localization of the IP3R at the protein level.
Immunostainings of these hiPSC-CMs stained positive for IP3R
with a strong subcellular distribution of the immunosignal around
the nucleus (Figure 6A) in a similar manner to that observed in
hESC-CMs [18], mouse ESC-CMs [26], and neonatal rat
cardiomyocytes [28].
Next, to evaluate for IP3-releasable Ca
2+ pool functionality and
participation in the regulation of Ca
2+-handling in hiPSC-CMs we
tested the effect of IP3R blockade utilizing two different
antagonistic approaches. First, to block IP3Rs we used the potent
cell-permeate inhibitor 2-aminoethoxydiphenyl borate (2-APB)
[25]. Application of 2-APB resulted in a significant dose-
dependent diminution of whole-cell [Ca
2+]i transients amplitude,
as was also reported in human ESC-CMs under these conditions
[18]. In addition, a slowing of whole-cell [Ca
2+]i transients
frequency was observed under the influence of 2-APB. Next we
applied U73122, a phosopholipase C blocker (PLC). Blocking the
activation of PLC inhibits a receptor-stimulated increase in the
production of the second messenger IP3 required as a trigger for
IP3R-mediated Ca
2+ release [25,27]. Superfusion of hiPSC-CMs
with U73122 also significantly decreased whole-cell [Ca
2+]i
transients amplitude and frequency. A U73122 PLC inhibitory
effect was also reported in mouse ESC-CMs [25]. These
observations imply that an IP3-releasable Ca
2+ pool is expressed
and functional in hiPSC-CMs and that the resulting IP3R-
mediated Ca
2+ release contributes to the modulation of Ca
2+-
handling of these cells.
Potential clinical and research applications
The hiPSC technology has raised significant excitement with
regards to its unique potential for regenerative medicine and for
the study of various genetic disorders as well as for drug discovery
and screening. In the current work we focused on the
characterization of the Ca
2+-handling properties of cardiomyo-
cytes differentiated from hiPSCs and demonstrated that they share
components that are present in adult cardiomyocytes, such as
functional RyR-mediated SERCA-sequestering SR Ca
2+ stores.
Importantly, the results of this study showing similar properties in
cardiomyocytes derived from different differentiation batches,
from different hiPSCs clones, and from different hiPSCs lines may
have important implications for their potential use for the
aforementioned tasks. The hiPSC-CMs may serve as attractive
cell-candidates for myocardial cell replacement therapy because of
their inherent cardiac-specific properties and the potential for
autologous therapy. Nevertheless, since functional compatibility
between donor hiPSC-CMs and host myocardium is likely to
contribute to an improved functional outcome of the cell
engraftment as well as a reduction in potential pro-arrhythmic
risk, detailed characterization of their Ca
2+-handling characteris-
tics is mandatory.
Similarly, phenotypic characterization of Ca
2+-handling in
these cells may be important if one wishes to utilize the iPSC
technology for establishment of personalized in-vitro models of
cardiac tissue for the development and testing of pharmacological
compounds targeting these functional properties. Finally, detailed
understanding of the Ca
2+-handling properties of hiPSC-CMs
generated from healthy individuals may be used as a future
reference when studying E-C coupling in hiPSC-CMs derived
from patients with genetic disorders involving Ca
2+-handling.
Such patient/disease-specific models can be established, for
example, from families suffering from catecholinergic polymor-
phic ventricular tachycardia (CPVT) [43,44], a potentially lethal
disorder resulting from mutations in either the ryanodine
receptor or calsequestrin.
Conclusion
In the present work we investigated basic Ca
2+-handling
components of hiPSC-CMs. Our results show that hiPSC-CMs
display functional and loaded RyR-regulated intracellular Ca
2+
stores. These stores can release Ca
2+ via RyRs and can reload
their content through SR Ca
2+ uptake utilizing functional SERCA
pumps. We present evidence showing the expression and
functionality of inositol-1,4,5-trisphosphate receptors (IP3Rs).
Furthermore, our findings demonstrate that the observed whole-
cell [Ca
2+]i transients in hiPSC-CMs depend on both sarcolemmal
Ca
2+ entry via L-type Ca
2+ channels and on intracellular store
Ca
2+ release. Taken together hiPSC-CMs recapitulate functional
key Ca
2+ handling proteins that have been shown to be expressed
and functional in mouse ESC-CMs [25,26,33], hESC-CMs
[18,19,30], and adult cardiac tissue [9]. The results of the current
study may have important implications for the potential
applications of the iPSC technology in basic and translational
cardiac research.
Supporting Information
Figure S1 Whole-cell [Ca
2+]i transients’ requirement
for Ca
2+ influx via L-type Ca
2+ channels as observed in
cardiomyocytes derived from different hiPSCs clones
and lines. Whole-cell [Ca
2+]i transients recorded from (A): hIH1
clone 1, (B): hIH1 clone 2 and (C): hfib2-5 before (left) and after
(right) application of nifedipine (1 mM). Abbreviations: F/Fo,
fluorescence (F) normalized to baseline fluorescence (Fo); sec,
seconds.
(PDF)
Figure S2 Caffeine and Ryanodine-sensitive Ca
2+ stores
as displayed in cardiomyocytes derived from different
hiPSCs clones and lines. (A) A line-scan presenting the effect
of 20 mM caffeine puff application (noted by the arrows) in hIH1
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PLoS ONE | www.plosone.org 10 April 2011 | Volume 6 | Issue 4 | e18037clone 1 (left), hIH1 clone 2 (middle) and hfib2-5 (right). (B) Line-
scan tracings of whole-cell [Ca
2+]i transients recorded from hIH1
clone 1 (top), hIH1 clone 2 (middle) and hfib2-5 (bottom) under
baseline conditions (left) and in the presence of 10 mM Ryanodine
(right). (C) Dose-response curve for ryanodine (5, 10, and 20 mM)
displayed as the percent decrease in [Ca
2+]i transients amplitude
from baseline values (n=5, **p,0.01 when mean absolute values
were compared to baseline values). Abbreviations: F/Fo, fluores-
cence (F) normalized to baseline fluorescence (Fo); sec, seconds.
(PDF)
Figure S3 The effects of SERCA inhibition in cardiomy-
ocytes derived from the hfib2-5 line. (A) Line-scan tracings
of whole-cell [Ca
2+]i transients in a representative hfib2-5 hiPSC-
CM under baseline conditions (left) and after 30 minutes (right) of
constant 10 mM thapsigargin exposure. (B) Caffeine-induced Ca
2+
transients (denoted by arrows) under baseline conditions (upper),
after 30 minutes (middle), and 32 minutes (lower) of thapsigargin
exposure. Abbreviations: F/Fo, fluorescence (F) normalized to
baseline fluorescence (Fo); sec, seconds.
(PDF)
Figure S4 The effect of IP3R inhibition in cardiomyo-
cytes derived from the hfib2-5 line. Whole-cell [Ca
2+]i
transients in representative hfib2-5 hiPSC-CMs before (left) and
after (right) 2-APB (2 mM) application (A) and before (left) and
after (right) U73122 (2 mM) application (B). Abbreviations: F/Fo,
fluorescence (F) normalized to baseline fluorescence (Fo); IP3R,
inositol-1,4,5-trisphosphate receptor; sec, seconds.
(PDF)
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